876 results found

The announcement clarifies the status of certified documents, product registration and movement requirements relating to medical devices in the context of the transition to the Regulation.

The Ministry of Health ("Ministry") published the Regulation on Pharmaceutical Businesses and Products in the Pharmaceutical Businesses ("Regulation") in the Official Gazette on 15 June 2022.

İlaç şirketleri tarafından gerçekleştirilen değer aktarımlarına ilişkin hiçbir kamuya ifşa kuralı bulunmamaktadır. Bununla birlikte

There is no public disclosure rule for value transfers made by pharmaceutical companies. However, according to the Regulation on the Promotional Activities of Pharmaceutical Products for Human Use ("Promotion Regulation")...

There is no public disclosure rule for value transfers made by pharmaceutical companies. However, according to the Regulation on the Promotional Activities of Pharmaceutical Products for Human Use...

The New Regulation on Licensing of Human Medicinal Products prepared by the TMMDA entered into force upon its publication in the Official Gazette numbered 31686 and dated December 11, 2021.

The Guideline on Scientific Meetings and Educational Activities to be Held Within the Scope of the Regulation on Sale, Advertisement and Promotion of Medical Devices ("Guideline")...

As per the Amending Regulation for Regulation on Licensing Medicinal Products for Human Use No. 31338 ("Amending Regulation") published on Official Gazette of December 18 2020...

Recently, law drafts about health protection, which include new prohibitions, have been submitted to the Parliament.

Turkey's Law No. 7557 introduces comprehensive healthcare reforms affecting physician practice limits, advertising restrictions, and pharmaceutical tracking systems.

Life sciences companies in Türkiye operate within a well-established regulatory framework governing interactions with healthcare professionals, where promotional activities face strict limitations and transparency requirements.

Through Circular numbered 2016/4 published by the Turkish Medicines and Medical Device Agency ("TITCK") an obligation for marketing authorization holders to apply to TITCK.

An obligation for marketing authorisation holders to apply to the TITCK and obtain permission for training and support programs for patients/healthcare professionals for...

2023 yılında yayımladığımız Sağlık Hukuku, Uluslararası Ticaret Hukuku ve Fikri Mülkiyet ve Teknoloji alanında Türkiye'deki önemli yasal gelişmeleri...

The healthcare industry in Central and Eastern Europe and Turkey is undergoing a digital transformation, with telemedicine at the forefront.

Sevi Firat, Founding Partner of Firat Izgi discusses the legal challenges facing pharmaceutical companies looking to penetrate the healthcare market in Turkey.

The IMS, leading provider of information, services and technology for the healthcare industry, covering markets in 100+ countries around the world has announced its latest report with regard to and in consideration of worldwide pharmaceutical industry as of July 2012.